Analysen zu BAT PLC (British American Tobacco)
| 21.02.24 | BAT Neutral | UBS AG | |
| 19.02.24 | BAT Overweight | Barclays Capital | |
| 19.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 15.02.24 | BAT Buy | Deutsche Bank AG | |
| 13.02.24 | BAT Neutral | UBS AG | |
| 12.02.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 12.02.24 | BAT Neutral | Goldman Sachs Group Inc. | |
| 08.02.24 | BAT Neutral | UBS AG | |
| 08.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 08.02.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 07.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 05.02.24 | BAT Buy | Jefferies & Company Inc. | |
| 30.01.24 | BAT Neutral | UBS AG | |
| 29.01.24 | BAT Neutral | UBS AG | |
| 23.01.24 | BAT Neutral | UBS AG | |
| 10.01.24 | BAT Neutral | JP Morgan Chase & Co. | |
| 12.12.23 | BAT Sector Perform | RBC Capital Markets | |
| 11.12.23 | BAT Buy | Jefferies & Company Inc. | |
| 08.12.23 | BAT Buy | UBS AG | |
| 08.12.23 | BAT Sector Perform | RBC Capital Markets | |
| 07.12.23 | BAT Buy | Deutsche Bank AG | |
| 07.12.23 | BAT Overweight | Barclays Capital | |
| 07.12.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 06.12.23 | BAT Overweight | Barclays Capital | |
| 06.12.23 | BAT Buy | Jefferies & Company Inc. | |
| 06.12.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 06.12.23 | BAT Buy | Jefferies & Company Inc. | |
| 06.12.23 | BAT Sector Perform | RBC Capital Markets | |
| 06.12.23 | BAT Buy | UBS AG | |
| 05.12.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 01.12.23 | BAT Buy | Jefferies & Company Inc. | |
| 01.12.23 | BAT Overweight | Barclays Capital | |
| 29.11.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 23.11.23 | BAT Sector Perform | RBC Capital Markets | |
| 17.11.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 02.11.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 13.10.23 | BAT Buy | Jefferies & Company Inc. | |
| 13.10.23 | BAT Buy | UBS AG | |
| 13.10.23 | BAT Buy | Jefferies & Company Inc. | |
| 05.10.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 13.09.23 | BAT Buy | UBS AG | |
| 29.08.23 | BAT Buy | UBS AG | |
| 22.08.23 | BAT Buy | Jefferies & Company Inc. | |
| 08.08.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 31.07.23 | BAT Neutral | JP Morgan Chase & Co. | |
| 28.07.23 | BAT Overweight | Barclays Capital | |
| 28.07.23 | BAT Neutral | Goldman Sachs Group Inc. | |
| 27.07.23 | BAT Buy | UBS AG | |
| 27.07.23 | BAT Buy | Deutsche Bank AG | |
| 26.07.23 | BAT Neutral | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 21.01.25 | Boeing Buy | Jefferies & Company Inc. | |
| 21.01.25 | Airbus Buy | Jefferies & Company Inc. | |
| 21.01.25 | Nordex Buy | Jefferies & Company Inc. | |
| 21.01.25 | Scout24 Hold | Jefferies & Company Inc. | |
| 21.01.25 | BASF Buy | Jefferies & Company Inc. | |
| 21.01.25 | DO buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.01.25 | Orsted Buy | UBS AG | |
| 21.01.25 | Orsted Neutral | JP Morgan Chase & Co. | |
| 21.01.25 | Siemens Energy Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.01.25 | Bayer Neutral | JP Morgan Chase & Co. | |
| 21.01.25 | LANXESS Underweight | JP Morgan Chase & Co. | |
| 21.01.25 | NVIDIA Buy | UBS AG | |
| 21.01.25 | Nemetschek Neutral | Goldman Sachs Group Inc. | |
| 21.01.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 21.01.25 | Nemetschek Neutral | UBS AG | |
| 21.01.25 | Ahold Delhaize Sell | UBS AG | |
| 21.01.25 | Novo Nordisk Buy | UBS AG | |
| 21.01.25 | Fresenius Medical Care Buy | Goldman Sachs Group Inc. | |
| 21.01.25 | Santander Buy | UBS AG | |
| 21.01.25 | LANXESS Buy | Goldman Sachs Group Inc. | |
| 21.01.25 | Apple Underperform | Jefferies & Company Inc. | |
| 20.01.25 | Daimler Truck Buy | Jefferies & Company Inc. | |
| 20.01.25 | Nemetschek Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 20.01.25 | Nemetschek Underweight | JP Morgan Chase & Co. | |
| 20.01.25 | LANXESS Kaufen | DZ BANK | |
| 20.01.25 | Verbund verkaufen | Deutsche Bank AG | |
| 20.01.25 | LANXESS Underperform | Jefferies & Company Inc. | |
| 20.01.25 | Brenntag Underweight | JP Morgan Chase & Co. | |
| 20.01.25 | Linde Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | Air Liquide Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | Symrise Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 20.01.25 | K+S Neutral | JP Morgan Chase & Co. | |
| 20.01.25 | WACKER CHEMIE Neutral | JP Morgan Chase & Co. | |
| 20.01.25 | LANXESS Underweight | JP Morgan Chase & Co. | |
| 20.01.25 | Evonik Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | Covestro Neutral | JP Morgan Chase & Co. | |
| 20.01.25 | BASF Neutral | JP Morgan Chase & Co. | |
| 20.01.25 | Akzo Nobel Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | Scout24 Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | Prosus Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | Delivery Hero Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | AUTO1 Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | Deutsche Bank Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | BNP Paribas Neutral | JP Morgan Chase & Co. | |
| 20.01.25 | Siemens Energy Neutral | JP Morgan Chase & Co. | |
| 20.01.25 | Merck Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | Air Liquide Overweight | JP Morgan Chase & Co. | |
| 20.01.25 | STRATEC Buy | Warburg Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.